Enteric disease testing market is expected to have a significant growth rate during the forecast period. The market is estimated to reach USD 4.9 billion by the year 2025. Enteric diseases are caused due to indigestion of contaminated food. These diseases may occur due to lack of proper maintenance of hygiene and sanitation in the surroundings. World health organization’s survey stated that nearly 2.2 million people are getting affected by water-borne diarrheal diseases. Harsh climatic changes are also a reason for the spread of these diseases.
- Growing incidences of infectious disease along with rising population are accelerating the demand of the market. In addition, the market is driven by increasing awareness programs towards healthy lifestyles. The rise in the campaigns especially in the rural areas with the support from government is prompting the demand of the market.
- However, the lack of skilled physicians in analyzing the reports due to less training programs is slowly declining the growth of the market. The challenging factor for the growth of the market is the high cost for maintenance of the modern diagnostic devices.
- Growth opportunities for the market lie in the increasing research and developments to ensure better diagnostic and therapeutic process. Unavailability of the drinking water and lack of knowledge over the safety standards are gearing up the growth of the market. The increasing scale of healthcare centers in every region is propelling the growth of the market.
Based on the diagnostics, the market is segmented into diagnostics assays and rapid tests, testing of stool specimens, complete blood count test, blood culture test, urine test, antibody test, vaccines, antibiotics, and many others.
North America expected to have the majority of the shares in the Global Market
Regionally, the market is led by North America by owing to the adoption of the latest technological developments and implementing them successfully. Following North America, Europe is witnessed to hold the largest shares of the market. Increasing awareness programs and growing prevalence to overcome enteric diseases are broadening the demand of the market. The Asia Pacific is to have significant growth rate in the coming years with the increasing support from the government activities. Middle East & Africa is to register the highest CAGR in the near future.
Some of the players included in the enteric disease testing market are Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., Biomerieux, Bio-Rad, Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Inc, Quest Diagnostics and Trinity Biotech.
This research report includes following segmentation for the Global Enteric Disease Testing Market size and forecast until 2025.
Enteric Disease Testing Market Analysis - By Therapeutics:
- E. coli
- Rotavirus (REOVIRUS)
Enteric Disease Testing Market Analysis - By Technologies
- Flow Cytometer
- Diagnostic Imaging
- Gel Micro-droplets
- Molecular Diagnostics
- Monoclonal Antibodies
- Differential Light Scattering
- Information Technology
- Artificial Intelligence
Enteric Disease Testing Market By Geography
- North America
- Asia-Pacific (APAC)
- Rest of World
Request Sample Brochure of the Report to view TOC